KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.03 per share a year ago.
KORU Medical Systems, Inc. (KRMD) Q4 2025 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.03 per share a year ago.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JC Joseph Castro Nuveen LLC | 55,330 | $198,081 | $221,320 | $23,239 | 11.73% |
Alexandra Stickelman Root Financial Partners, LLC | 19 | $82 | $76 | -$6 | -7.32% |
| MS Mark Schafer Police & Firemen's Retirement System of New Jersey | 8,255 | $29,553 | $33,020 | $3,467 | 11.73% |
| BM Berkeley Meredith Hughes Financial Services LLC | 1 | $6 | $4 | -$2 | -33.33% |
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | Linda Tharby CEO | NASDAQ (CM) Exchange | 759910102 CUSIP |
| US Country | 80 Employees | - Last Dividend | - Last Split | 20 Mar 1996 IPO Date |
KORU Medical Systems, Inc. is a pioneering firm that specializes in the development and manufacturing of essential medical devices and supplies, with its influence extending both within the United States and internationally. Founded in 1980 and headquartered in Mahwah, New Jersey, the company has cemented its position as a critical provider in the healthcare sector. KORU's primary mission revolves around enhancing the lives of patients battling chronic illnesses through the provision of innovative infusion systems, particularly targeting individuals suffering from primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. These contributions significantly improve the quality of life for their users, allowing for life-saving therapies to be more accessible, efficient, and comfortable.
KORU Medical Systems offers a diverse range of products designed to meet the needs of patients requiring infusion therapies. These offerings include: